Building Your Care Team & First Visit Prep
At a Glance
Children with SPG89 benefit from a coordinated care team tailored to their symptoms, age, and goals. Before the first specialist visit, families should bring the full AMFR genetic report, MRI images and report, developmental history, and a short movement video when helpful.
Building a care team for an ultra-rare condition like SPG89 is different from managing a common childhood illness. You are assembling a group of specialists who will collaborate with you over many years [1]. Because your local doctors may never have seen a case of AMFR-related spastic paraplegia, your role as the central coordinator is vital [2].
A Goal- and Phenotype-Based Care Team
Each member of the team looks at a different aspect of health. In a coordinated “multidisciplinary” model, specialists are added based on the child’s specific symptoms, age, and goals [1].
- Pediatric Neurologist or Neurogeneticist: They monitor the overall health of the nervous system and help interpret genetic results [2].
- Physical Medicine & Rehabilitation (PM&R) Physician: Also called a physiatrist, they specialize in “function”—managing spasticity medications, injections, and bracing [1].
- Physical (PT) and Occupational (OT) Therapists: Experts who focus on leg strength, gait, and daily living skills [3][1].
- Urologist: Consulted if there are urinary symptoms, abnormal residual volumes, or recurrent infections to monitor for neurogenic bladder [4][5].
- Genetic Counselor: They help you understand what the AMFR mutation means for your family and can assist in screening relatives [6].
- Additional Specialists: Depending on the child, developmental pediatrics, speech-language therapy, psychology, or social work may also be incorporated.
Preparing for Specialist Visits
The first visit with a specialist is an opportunity to set the tone for your child’s care. Being prepared with records ensures that the doctor spends time assessing your child rather than hunting for paperwork [1].
What to Prepare
Ask the clinic beforehand what records they need and in what format:
- Genetic Test Reports: Provide the full, multi-page report from the lab. The specific variant of the AMFR gene matters [7].
- MRI Imaging: While many hospitals accept secure digital transfer or DICOM uploads, some may request a physical disc. Always provide the formal written report as well [8].
- Milestone History: A summary of developmental milestones. If they are losing skills (regression), this is critical information [9].
- Supplemental Videos: A short video of your child walking or moving in a familiar environment can be a helpful supplement to the physical exam [10].
Navigating the Visit
When you meet a new specialist, look for someone who is honest about the limits of current knowledge but is willing to consult with experts [11].
Be prepared to discuss your child’s “social” health—how they are doing in school, whether they are in pain, and what their energy levels are like [10]. This information helps the team determine if a care plan is truly supporting quality of life [12]. A dedicated team will focus on your child’s unique strengths and potential, ensuring they have the support they need to thrive.
Common questions in this guide
Which specialists should be part of my child’s SPG89 care team?
What should I bring to my child’s first SPG89 specialist appointment?
How can I prepare for a doctor who has not treated SPG89 before?
What does a genetic counselor do for a family affected by SPG89?
What information should I share beyond my child’s medical records?
How should we discuss treatment choices for SPG89?
Get notified when new evidence is published on spastic paraplegia 89, autosomal recessive.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.
Mania-Pâris L, Ewenczyk C, Nicolas G, et al.
Revue neurologique 2025; (181(6)):471-482 doi:10.1016/j.neurol.2025.05.001.
PMID: 40450402 - 2
Hereditary spastic paraplegia: a practical approach.
Bradley M, Kalfat A, Walsh RA, et al.
Practical neurology 2026; doi:10.1136/pn-2026-005344.
PMID: 42816178 - 3
The therapeutic effects of physical treatment for patients with hereditary spastic paraplegia: a narrative review.
Di Ludovico A, Ciarelli F, La Bella S, et al.
Frontiers in neurology 2023; (14()):1292527 doi:10.3389/fneur.2023.1292527.
PMID: 38093754 - 4
Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4).
Rattay TW, Boldt A, Völker M, et al.
Journal of neurology 2020; (267(2)):369-379 doi:10.1007/s00415-019-09573-w.
PMID: 31646384 - 5
Urological dysfunction in patients with hereditary spastic paraplegia.
Joussain C, Levy J, Charlanes A, et al.
Neurourology and urodynamics 2019; (38(4)):1081-1085 doi:10.1002/nau.23957.
PMID: 30848841 - 6
Increased Diagnostic Yield of Spastic Paraplegia with or Without Cerebellar Ataxia Through Whole-Genome Sequencing.
Kim A, Kumar KR, Davis RL, et al.
Cerebellum (London, England) 2019; (18(4)):781-790 doi:10.1007/s12311-019-01038-0.
PMID: 31104286 - 7
AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model.
Deng R, Medico-Salsench E, Nikoncuk A, et al.
Acta neuropathologica 2023; (146(2)):353-368 doi:10.1007/s00401-023-02579-9.
PMID: 37119330 - 8
Systematic Analysis of Brain MRI Findings in Adaptor Protein Complex 4-Associated Hereditary Spastic Paraplegia.
Ebrahimi-Fakhari D, Alecu JE, Ziegler M, et al.
Neurology 2021; (97(19)):e1942-e1954 doi:10.1212/WNL.0000000000012836.
PMID: 34544818 - 9
Childhood-onset hereditary spastic paraplegia: at the crossroads between neurodevelopment and neurodegeneration.
Espasandin-Hueter N, Salazar-Villacorta A, Escudero JM, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2026; (65()):50-65 doi:10.1016/j.ejpn.2026.10.002.
PMID: 42976539 - 10
Stumbling, struggling, and shame due to spasticity: a qualitative study of adult persons with hereditary spastic paraplegia.
Kerstens HCJW, Satink T, Nijkrake MJ, et al.
Disability and rehabilitation 2020; (42(26)):3744-3751 doi:10.1080/09638288.2019.1610084.
PMID: 31079503 - 11
Outcome Measures and Biomarkers for Clinical Trials in Hereditary Spastic Paraplegia: A Scoping Review.
Siow SF, Yeow D, Rudaks LI, et al.
Genes 2023; (14(9)) doi:10.3390/genes14091756.
PMID: 37761896 - 12
Disease Severity and Motor Impairment Correlate With Health-Related Quality of Life in AP-4-Associated Hereditary Spastic Paraplegia.
Jordan C, Geisel G, Alecu JE, et al.
Neurology. Genetics 2021; (7(4)):e605 doi:10.1212/NXG.0000000000000605.
PMID: 34295967
This page provides general information about organizing care for a child with SPG89 and preparing for specialist visits. It is for informational purposes only and does not constitute medical advice; your child’s clinicians should guide decisions about testing, treatment, and follow-up.